Pharma Journalist - Page 51 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap

Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients

Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology

Bayer and Broad Institute extend cancer therapy research collaboration

Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)

Sosei Heptares Will Receive US$3.75 Million Payment in Multi-Target Partnership

FDA approves Novartis Cosentyx as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade

GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepirovirsen

Kite and Epic Bio Announce Collaboration to Develop New Therapies for Cancer

Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics